Prosecution Insights
Prosecution Insights
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (75%) |
| §112 only | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OGUNBIYI, OLUWATOSIN A | 1 | 63.5% | +41.8% |
| CAIN, JENNIFER LYNN | 1 | 43.8% | +66.3% |
| BOECKELMAN, JACOB A | 1 | 36.2% | +46.0% |
| BYRD, BRIGID K | 1 | 70.9% | +48.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17280085 | SURGICAL LINE FIXATION DEVICE AND METHODS OF USE THEREOF | BYRD, BRIGID K | 124d overdue |
| 18268146 | NUTRACEUTICAL COMPOUNDS USEFUL IN THE TREATMENT OF CORONAVIRUS DISEASE | CAIN, JENNIFER LYNN | 82d |
| 18368505 | VACCINE COMPOSITIONS AND METHODS OF USING THE SAME | OGUNBIYI, OLUWATOSIN A | 84d |
| 17782949 | COMPOSITIONS AND METHODS TO MODULATE GLUCOSE HOMEOSTASIS | BOECKELMAN, JACOB A | — |
| Art Unit | Apps |
|---|---|
| 1655 | 2 |
| 1645 | 1 |
| 3771 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18368505 | VACCINE COMPOSITIONS AND METHODS OF USING THE SAME | OGUNBIYI, OLUWATOSIN A | 1645 | §112 | Non-Final OA | 84d | Pending | Sep 14, 2023 |
| 18268146 | NUTRACEUTICAL COMPOUNDS USEFUL IN THE TREATMENT OF CORONAVIRUS DISEASE | CAIN, JENNIFER LYNN | 1655 | §103 | Non-Final OA | 82d | Pending | Jun 16, 2023 |
| 17782949 | COMPOSITIONS AND METHODS TO MODULATE GLUCOSE HOMEOSTASIS | BOECKELMAN, JACOB A | 1655 | §103 | Non-Final OA | — | Pending | Jun 06, 2022 |
| 17280085 | SURGICAL LINE FIXATION DEVICE AND METHODS OF USE THEREOF | BYRD, BRIGID K | 3771 | §103 | Final Rejection | 124d overdue | Pending | Mar 25, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial